November 6, 2009 - Acceletronics announced here at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO) that it will be introducing the new Theraview KV Imaging IGRT system for radiation oncology facilities.

The Theraview system is the first cost-effective IGRT solution that can be mounted to any brand of linear accelerator, whether Varian, Elekta or Siemens, allowing a seamless upgrade to KV-Imaging IGRT (Image Guided Radiation Therapy).

“The KV-Imager is a natural extension of the MV-based electronic portal imaging device (EPID) IGRT solution that Theraview has been marketing and selling worldwide for many years,” states James Young, VP of Marketing for Acceletronics. After completing two successful beta tests at U.S. facilities, we are thrilled to offer the product nationally.”

The Theraview KV IGRT system is offered in single-head and dual-head configurations, and supplements the Theraview MV IGRT system (marketed as an electronic portal imaging device, or EPID).

The TheraView system is manufactured by Cablon Medical BV, dba Theraview Technology in the United States, and is distributed by Acceletronics, Inc., and Acceletronics Digital Imaging, LLC.

The TheraView system allows for more precise radiation therapy treatment delivery through the use of IGRT (Image Guided Radiation Therapy). Immediately prior to each session for the delivery of radiation, the system takes a real-time x-ray image of the patient and compares it to the reference image taken during the treatment planning. Theraview then instructs the therapist of any changes, thereby allowing the therapist to reposition the patient, as necessary, to ensure the delivery of radiation is accurate.

TheraView Target Check software includes automated treatment beam shape verification and patient position verification which provides precision and control to clinicians needed for both conventional, image guided (IGRT) and intensity modulated radiation therapy (IMRT).

The Theraview system is adaptable to Varian, Elekta and Siemens linear accelerator systems and is available with the advanced Theraview Couch Set-Up Assistant (TCSA) option to facilitate rapid couch movement.

For more information: www.theraview.com


Related Content

News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Image Guided Radiation Therapy (IGRT)

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
News | Radiology Imaging

December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement ...

Time December 12, 2019
arrow
News | Radiation Therapy

October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...

Time October 22, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation therapy to targeted tumors while simultaneously providing continuous magnetic resonance imaging (MRI).

Time October 08, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Time September 16, 2019
arrow
Subscribe Now